FdaApplication
ANDA 209111
Identifiers
- fda_app_no: ANDA209111
Properties
| Property | Value |
|---|---|
| applicant_name | NESHER PHARMACEUTICALS USA LLC |
| application_type | ANDA |
| approval_date | 2017-06-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 10MG | CAPSULE, EXTENDED RELEASE;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 15MG | CAPSULE, EXTENDED RELEASE;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 5MG | CAPSULE, EXTENDED RELEASE;ORAL |
3 products